Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc.

NASDAQ:MDGL

Overview | Financials
Company Name Madrigal Pharmaceuticals, Inc.
Symbol MDGL
Currency USD
Price 292.76
Market Cap 6,500,238,108
Dividend Yield 0%
52-week-range 200.63 - 377.46
Industry Biotechnology
Sector Healthcare
CEO Mr. William J. Sibold
Website https://www.madrigalpharma.com

An error occurred while fetching data.

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic

Related Stocks

Atrion Corporation logo

Atrion Corporation

ATRI

459.92 USD

Cronos Group Inc. logo

Cronos Group Inc.

CRON

2.09 USD

Outset Medical, Inc. logo

Outset Medical, Inc.

OM

19.51 USD

RadNet, Inc. logo

RadNet, Inc.

RDNT

60.16 USD

Revolution Medicines, Inc. logo

Revolution Medicines, Inc.

RVMD

40.47 USD

Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc.

AGIO

30.17 USD

NGM Biopharmaceuticals, Inc. logo

NGM Biopharmaceuticals, Inc.

NGM

1.54 USD

Financials

Numbers are in millions USD

Numbers are in millions USD